en · de · es
selank-notes.peptides7250.com › Faq › Mechanism And Evidence Status — Beginner to Advanced

Mechanism And Evidence Status — Beginner to Advanced

By Editorial Desk · published 2026-02-19 · last reviewed 2026-03-30 · Faq

Pro-Gly-Pro is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2026-03-30. Where a claim depends on a specific study, the study is described rather than over-claimed.

Mechanism and Evidence Status

Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.

Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.

Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.

Mechanism and Evidence Base

Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.

Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.

Selank at a glance

PropertyValueNotes
Primary route studiedIntranasalAlso examined parenterally in animal work
Reported plasma half-lifeMinutes to tens of minutesValues vary widely between reports
Main model systemsRodent behavioural and cell assaysHuman trials are few and small
Principal proposed targetsGABA-A receptor, GABA transaminaseMonoamine and neurotrophic pathways also reported
Evidence gradePreliminaryLimited independent replication

Background and Molecular Identity

Enzymatic stability motivates the extra three residues at the carboxyl end. Native tuftsin is cleaved quickly by circulating aminopeptidases and carboxypeptidases, which limits its duration of action and its usefulness as a tool compound. Extending the chain with proline-rich segments is a common design tactic because proline constrains the backbone and slows proteolysis. The same Pro-Gly-Pro motif appears in other Russian-developed peptides of the era. Whether the full seven-residue chain is required for activity, or whether it acts mainly as a prodrug releasing tuftsin, remains unresolved.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its four N-terminal residues reproduce tuftsin, a tetrapeptide fragment of the immunoglobulin heavy chain, while the C-terminal Pro-Gly-Pro extension is a synthetic addition. The peptide has a molecular mass near 752 daltons and carries a net positive charge at physiological pH because of the arginine and lysine side chains. Published indexes list it under the name Selank and the sequence abbreviation TKPRPGP. Solid-phase peptide synthesis is the standard production route for research quantities.

Related pages on this site

Peptide Identity and Structure

The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.

Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.

Storage, Analysis, and Regulatory Status

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.

Selank is a hydrophilic peptide and dissolves readily in water and in aqueous buffers. The lyophilised powder is typically a white to off-white solid. Because short peptides are prone to hydrolysis and oxidation, handling benefits from limiting exposure to heat, moisture and strong light. Working solutions are commonly prepared in sterile water or saline, and repeated freeze-thaw cycles are avoided to reduce aggregation and loss of activity. These practices reflect general laboratory convention rather than published stability specifications.

Analytical Methods and Material Handling

Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.

Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.

Notes from published material

== Applications == Coatings can be both decorative and have other functions. A pipe carrying water for a fire suppression system can be coated with a red (for identification) anticorrosion paint. Most coatings to some extent protect the substrate, such as maintenance coatings for metals and concrete. A decorative coating can offer a particular reflective property, such as high gloss, satin, matte, or flat appearance. A major coating application is to protect metal from corrosion. Automotive coatings are used to enhance the appearance and durability of vehicles. These include primers, basecoats, and clearcoats, primarily applied with spray guns and electrostatically. The body and underbody of automobiles receive some form of underbody coating. Such anticorrosion coatings may use graphene in combination with water-based epoxies. Coatings are used to seal the surface of concrete, such as seamless polymer/resin flooring, bund wall/containment lining, waterproofing and damp proofing concrete walls, and bridge decks. Compare with tradition coatings, moisture curing polyurethane has been widely used because of the excellent adaptability and ease of construction. The mechanical properties could be enhanced by introducing multiple hydrogen bonds and optimize the microphase separation structure. Most roof coatings are designed primarily for waterproofing, though sun reflection (to reduce heating and cooling) may also be a consideration. They tend to be elastomeric to allow for movement of the roof without cracking within the coating membrane.

==== Iraq War ==== Hitchens employed the term "Islamofascist" and supported the Iraq War, causing his critics to consider him a "neoconservative". Hitchens, however, refused to embrace this designation, insisting, "I'm not any kind of conservative". In 2004, Hitchens stated that neoconservative support for US intervention in Iraq convinced him that he was "on the same side as the neo-conservatives" when it came to contemporary foreign policy issues, and characterized himself as an unqualified "supporter of Paul Wolfowitz." He referred to his associations as "temporary neocon allies". In this period he opined that "the Bush administration [...] has redefined the lazy term 'conservative' to mean someone who is impatient with the status quo." In the years after the fatwa issued against Salman Rushdie in response to his novel The Satanic Verses, Hitchens became increasingly critical of what he called "excuse making" on the left. At the same time, he was attracted to the foreign policy ideas of some on the Republican-right that promoted pro-liberalism intervention, especially the neoconservative group that included Paul Wolfowitz. Around this time, he befriended the Iraqi dissident and businessman Ahmed Chalabi. Hitchens argued the case for the Iraq War in a 2003 collection of essays entitled A Long Short War: The Postponed Liberation of Iraq, and participated in public debates on the topic with George Galloway, Scott Ritter, and his brother Peter Hitchens.

== Methods == Scarification is not a precise practice; variables, such as skin type, cut depth, and how the wound is treated while healing, can make the outcome unpredictable compared to other forms of body modification. A method that works on one person may not work on another. The scars tend to spread as they heal, so final designs are usually simple, the details being lost during healing.Some common scarification techniques include: Ink rubbing Tattoo ink (or similar agent) is rubbed into a fresh cut to add color or extra visibility to the scar. Most of the ink remains in the skin as the cut heals. This was how tattoos were initially done before the use of needles to inject ink. Skin removal/skinning Skin removal allows for larger markings than simple cutting. The skin is raised with a hook or edged thorn and removed with a razor blade. This process can take many hours, and often requires repeated removal of scabs for best visibility of the scars. Packing An inert material such as clay or ash is packed into the wound; massive hypertrophic scars are formed during healing as the wound pushes out the substance that had been inserted into the wound. Inflammatory substances can be used to improve keloid formation.

After the Rollercoaster Tour to support the album, the band concentrated on cracking the United States' market, with an appearance on David Letterman's show, and a tour as part of the Lollapalooza line-up, which William later described as "the worst experience of our lives," followed by their own headlining tour. In December 1992, the Reids again lost their rhythm section, with Ben Lurie returning and Steve Monti joining on drums. Another compilation was released in 1993, The Sound of Speed, before they returned to the studio to record their fifth album proper, Stoned & Dethroned which would see release in 1994, and featured guest appearances from Shane MacGowan and William's then-girlfriend Hope Sandoval. The album was originally planned as an acoustic album, but this idea was abandoned because, in Jim's words, "We couldn't do enough interesting things with acoustic guitars to make an album". In the 1995 EP released under American Records, a number of new works and B-sides were published which were later collected in the album Munki. After the release of the 1995 compilation Hate Rock 'N' Roll, the Mary Chain parted ways with Blanco y Negro, their record label of over a decade, and re-signed to their original label Creation Records, and Sub Pop in America. The band now included former Lush bassist Phil King. They then recorded 1998's Munki album, which would turn out to be their last before splitting the following year. Munki was commercially the least successful album the band released, peaking at number forty-seven in the UK Album Chart.

Su ji (素鸡, "vegetarian chicken"), either by being rolled up or by being pressed together and fried. Baiye jie (百叶结 "baiye knots"), by slicing into 2 cm × 10 cm slices and tying the slice up. Various dishes that roll other food items inside a piece of baiye.

Sources: en.wikipedia.org

Further detail

{\displaystyle {\begin{aligned}{\bar {I}}_{1}&=J^{-2/3}~I_{1}~;~~I_{1}=\lambda _{1}^{2}+\lambda _{2}^{2}+\lambda _{3}^{2}~;~~J=\det({\boldsymbol {F}})\\{\bar {I}}_{2}&=J^{-4/3}~I_{2}~;~~I_{2}=\lambda _{1}^{2}\lambda _{2}^{2}+\lambda _{2}^{2}\lambda _{3}^{2}+\lambda _{3}^{2}\lambda _{1}^{2}\end{aligned}}}

When Stephen was captured in 1141 he was imprisoned in the castle, but when Robert was captured by Stephen's forces, Matilda was forced to exchange Stephen for Robert. Her son Henry, later to become Henry II of England, was kept safe in the castle, guarded and educated by his uncle Robert. The castle was later taken into royal hands, and Henry III spent lavishly on it, adding a barbican before the main west gate, a gate tower, and magnificent hall. The castle was also used to imprison Eleanor, Fair Maid of Brittany from 1224, under relatively comfortable conditions, almost to her death in 1241. The Earl of Gloucester had founded the Benedictine priory of St James in 1137. In 1140 St Augustine's Abbey was founded by Robert Fitzharding, a wealthy Bristolian who had loyally supported the Earl and Matilda in the war. As a reward for this support he would later be made Lord of Berkeley. The abbey was a monastery of Augustinian canons. In 1148 the abbey church was dedicated by the bishops of Exeter, Llandaff, and St. Asaph, and during Fitzharding's lifetime the abbey also built the chapter house and gatehouse. In 1172, following the subjugation of the Pale in Ireland, Henry II gave Bristolians the right to reside in and trade from Dublin. The medieval Jewish community of Bristol was one of the smaller communities in England. The Jews of Bristol were accused in a blood libel in 1183, but not many details are known. At the end of the 12th century, an archa was established in the city, without which Jews would not have been legally allowed to conduct business.

=== Eye Care === Any individual with diabetes is at risk for diabetes-related eye conditions and it is recommended to have an initial diabetic eye exam screening and subsequent annual comprehensive dilated eye exam with either an optometrist or ophthalmologist. Diabetic retinopathy is the most common complication of diabetes and one of the leading causes of blindness worldwide. Individuals with diabetes are at greater risk for developing eye conditions such as glaucoma and cataracts earlier or more frequently. Blood sugar control continues to be the most effective way to decrease the risk or slow the progression of diabetic retinopathy.

α-Melanocyte-stimulating hormone (α-MSH) is an endogenous peptide hormone and neuropeptide of the melanocortin family, with a tridecapeptide structure and the amino acid sequence Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2. It is the most important of the melanocyte-stimulating hormones (MSHs) (also known as melanotropins) in stimulating melanogenesis, a process that in mammals (including humans) is responsible for pigmentation primarily of the hair and skin. It also plays a role in feeding behavior, energy homeostasis, sexual activity, and protection against ischemia and reperfusion injury. α-MSH is a non-selective full agonist of the melanocortin receptors MC1 (Ki = 0.230 nM), MC3 (Ki = 31.5 nM), MC4 (Ki = 900 nM), and MC5 (Ki = 7160 nM), but not MC2 (which is exclusive for adrenocorticotropic hormone (ACTH)). Activation of the MC1 receptor is responsible for its effect on pigmentation, whereas its regulation of appetite, metabolism, and sexual behavior is mediated through both the MC3 and MC4 receptors. It is generated as a proteolyic cleavage product from ACTH (1-13), which is in turn a cleavage product of proopiomelanocortin (POMC). A few synthetic analogues of α-MSH have been investigated as medicinal drugs due to their photoprotective effects against ultraviolet (UV) radiation from the sun. They include afamelanotide (melanotan) and melanotan II, the former of which has been approved as a treatment to reduce photosensitivity in erythropoietic protoporphyria in the United States.

== Current state of the industry == A tablet counter has become a standard in more than 30,000 sites in 35 countries (as of 2010) (including many non-pharmacy sites, such as manufacturing facilities that use a counting machine as a check for small items). During the 1990s through 2012, numerous new pharmacy automation products came to market. During this timeframe, counting technologies, robotics, workflow management software, and interactive voice recognition (IVR) systems for retail (both chain and independent), outpatient, government, and closed-door pharmacies (mail order and central fill) were all introduced. Additionally, the concept of scalability - of migrating from an entry-level product to the next level of automation (e.g., counting technology to robotics) - was introduced and subsequently launched a new product line in 1997. Pharmacists are transitioning to automation. As the industry evolves and customer expectations grow, automation is emerging as necessity rather than luxury. Especially for independent pharmacies, automation becomes a means of keeping up with the competition of large chain pharmacies.

Sources: en.wikipedia.org

Frequently asked questions

What mechanisms are proposed for Selank?

Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.

What happens to Selank after intranasal dosing?

The peptide enters plasma rapidly and is broken down by ordinary proteases into amino acids and shorter fragments. Reported half-lives are short. Whether meaningful amounts of the intact molecule reach the brain is an open question.

How strong is the clinical evidence?

Most clinical reports are small, published in Russian and not independently replicated. English-language reviews highlight the absence of large randomised trials. Conclusions about efficacy should be treated as provisional.

What mechanisms are proposed for Selank?

Reports describe effects on GABA-A receptor expression, monoamine turnover, and neurotrophic factor levels. These are proposed mechanisms drawn mainly from animal models. No single molecular target has been established.

Network